Health and Medicine

Respiratory syncytial virus (RSV) is the major cause of life-threatening viral pneumonia in infants worldwide, yet despite repeated efforts, scientists have been unable to develop an effective vaccine against it.

Physical therapists use questionnaires to identify patients at risk for slow recovery, but those tools aren’t tailored to assess the resiliency of injured U.S. military personnel.

Medical studies have established that people with type 2 diabetes are more susceptible to fractures, but the biological process that weakens their bones is not understood.

Vanderbilt-Ingram Cancer Center (VICC) is leading a Phase 3 global trial of a cancer therapy that was initially tested and validated in a VICC research laboratory. One of the first patients treated with the therapy came to VICC after a bump on the head led to an unexpected cancer diagnosis.

A visionary $6 million gift to Vanderbilt from the Eskind family ensures that the Eskind Biomedical Library will support the next generation of scientists, physicians, students and patients.

Homecoming came early this year for Vanderbilt alumnus David Sweatt, who joined the faculty as chair of Pharmacology this summer, 30 years after receiving his Ph.D. from the department he now leads.

In what could be a way to predict which children might be vulnerable to anxiety disorders, a Vanderbilt study has shown that an altered prefrontal cortex function in the brain marks a heightened anxiety risk in children.